The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.
1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
Every 66 seconds, someone in the United States develops Alzheimer’s.
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
Read TARCC's Latest Facebook Posts:
TARCC is looking for informal caregivers of adults with Alzheimer’s disease or other dementias to take part in a study that teaches care partners techniques to cope with difficult situations.
Examining neuronal loss and degeneration, TARCC-funded Junior Investigator Hua Liu at UTMB contributed to a study of the Zika virus and how it induces progressive neuronal and vascular damage, and retinal inflammation. actaneurocomms.biomedcentral.com/articles/10.1186/s40478-021-01195-6
The Texas Health and Human Services is proud to announce the launch of the Texercise Prevents: Malnutrition in Older Texans awareness campaign. Go to their website to learn about the role of good nutrition in healthy aging. www.hhs.texas.gov/services/health/wellness/texercise/healthy-eating